Get the Stockscreener App
356.77
2.51%
-9.20
Overview
News
Price History
Option Chain
Financials
Why MSFT Down?
Discussions
Forecast
Stock Split
Dividend History
Microsoft Corporation stock is traded at $356.77, with a volume of 37.50M.
It is down -2.51% in the last 24 hours and down -9.16% over the past month.
Microsoft develops and licenses consumer and enterprise software. It is known for its Windows operating systems and Office productivity suite. The company is organized into three equally sized broad segments: productivity and business processes (legacy Microsoft Office, cloud-based Office 365, Exchange, SharePoint, Skype, LinkedIn, Dynamics), intelligence cloud (infrastructure- and platform-as-a-service offerings Azure, Windows Server OS, SQL Server), and more personal computing (Windows Client, Xbox, Bing search, display advertising, and Surface laptops, tablets, and desktops).
See More
Previous Close:
$365.97
Open:
$361.9
24h Volume:
37.50M
Relative Volume:
1.13
Market Cap:
$2.65T
Revenue:
$305.45B
Net Income/Loss:
$119.26B
P/E Ratio:
22.32
EPS:
15.9828
Net Cash Flow:
$77.41B
1W Performance:
-6.57%
1M Performance:
-9.16%
6M Performance:
-30.24%
1Y Performance:
-8.66%
1-Day Range:
$356.51
$362.45
1-Week Range:
$356.51
$387.21
52-Week Range:
$344.79
$555.45
Microsoft Corporation Stock (MSFT) Company Profile
Name
Microsoft Corporation
Sector
Industry
Phone
425-882-8080
Address
ONE MICROSOFT WAY, REDMOND, WA
Compare MSFT vs ORCL, PLTR, CRWD, SNPS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MSFT
Microsoft Corporation
|
356.77 | 2.65T | 305.45B | 119.26B | 77.41B | 15.98 |
ORCL
Oracle Corp
|
139.66 | 401.67B | 64.08B | 16.40B | -24.74B | 5.5698 |
PLTR
Palantir Technologies Inc
|
143.06 | 342.15B | 4.48B | 1.63B | 2.10B | 0.6328 |
CRWD
Crowdstrike Holdings Inc
|
369.58 | 93.73B | 4.81B | -181.85M | 1.24B | -0.7398 |
SNPS
Synopsys Inc
|
380.47 | 72.88B | 8.00B | 1.10B | 2.28B | 6.4708 |
Microsoft Corporation Stock (MSFT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-25-26 | Reiterated | UBS | Buy |
| Mar-24-26 | Resumed | BofA Securities | Buy |
| Feb-09-26 | Downgrade | Melius | Buy → Hold |
| Feb-05-26 | Downgrade | Stifel | Buy → Hold |
| Feb-03-26 | Resumed | Piper Sandler | Overweight |
| Jan-29-26 | Reiterated | BMO Capital Markets | Outperform |
| Jan-29-26 | Reiterated | Barclays | Overweight |
| Jan-29-26 | Reiterated | Bernstein | Outperform |
| Jan-29-26 | Reiterated | Citigroup | Buy |
| Jan-29-26 | Reiterated | Deutsche Bank | Buy |
| Jan-29-26 | Reiterated | Evercore ISI | Outperform |
| Jan-29-26 | Reiterated | Goldman | Buy |
| Jan-29-26 | Reiterated | JP Morgan | Overweight |
| Jan-29-26 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jan-29-26 | Reiterated | Piper Sandler | Overweight |
| Jan-29-26 | Reiterated | Robert W. Baird | Outperform |
| Jan-29-26 | Reiterated | Stifel | Buy |
| Jan-29-26 | Reiterated | Wedbush | Outperform |
| Jan-29-26 | Reiterated | Wells Fargo | Overweight |
| Jan-26-26 | Reiterated | Stifel | Buy |
| Jan-23-26 | Reiterated | UBS | Buy |
| Jan-21-26 | Reiterated | Citigroup | Buy |
| Jan-21-26 | Reiterated | Mizuho | Outperform |
| Jan-12-26 | Reiterated | Barclays | Overweight |
| Jan-12-26 | Resumed | Goldman | Buy |
| Jan-08-26 | Reiterated | Wells Fargo | Overweight |
| Nov-18-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Nov-14-25 | Initiated | Robert W. Baird | Outperform |
| Oct-30-25 | Reiterated | BMO Capital Markets | Outperform |
| Oct-27-25 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-22-25 | Reiterated | Citigroup | Buy |
| Oct-17-25 | Reiterated | Mizuho | Outperform |
| Oct-06-25 | Reiterated | Wells Fargo | Overweight |
| Jul-31-25 | Reiterated | BMO Capital Markets | Outperform |
| Jul-31-25 | Reiterated | Barclays | Overweight |
| Jul-31-25 | Reiterated | Bernstein | Outperform |
| Jul-31-25 | Reiterated | BofA Securities | Buy |
| Jul-31-25 | Reiterated | Jefferies | Buy |
| Jul-31-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-31-25 | Reiterated | Mizuho | Outperform |
| Jul-31-25 | Reiterated | Morgan Stanley | Overweight |
| Jul-31-25 | Reiterated | Oppenheimer | Outperform |
| Jul-31-25 | Reiterated | TD Cowen | Buy |
| Jul-31-25 | Reiterated | UBS | Buy |
| Jul-31-25 | Reiterated | Wedbush | Outperform |
| Jul-31-25 | Reiterated | Wells Fargo | Overweight |
| Jul-22-25 | Reiterated | Citigroup | Buy |
| Jul-16-25 | Reiterated | Cantor Fitzgerald | Overweight |
| Jul-16-25 | Reiterated | Mizuho | Outperform |
| Jul-09-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-02-25 | Reiterated | DA Davidson | Buy |
| Jun-25-25 | Reiterated | Wedbush | Outperform |
| Jun-11-25 | Reiterated | Citigroup | Buy |
| May-01-25 | Reiterated | BMO Capital Markets | Outperform |
| May-01-25 | Reiterated | Barclays | Overweight |
| May-01-25 | Reiterated | Evercore ISI | Outperform |
| May-01-25 | Reiterated | Goldman | Buy |
| May-01-25 | Reiterated | JP Morgan | Overweight |
| May-01-25 | Reiterated | Mizuho | Outperform |
| May-01-25 | Reiterated | Piper Sandler | Overweight |
| May-01-25 | Reiterated | RBC Capital Mkts | Outperform |
| May-01-25 | Reiterated | Raymond James | Outperform |
| May-01-25 | Reiterated | Scotiabank | Sector Outperform |
| May-01-25 | Reiterated | Stifel | Buy |
| May-01-25 | Reiterated | Wedbush | Outperform |
| Apr-17-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-16-25 | Reiterated | BMO Capital Markets | Outperform |
| Apr-16-25 | Reiterated | Morgan Stanley | Overweight |
| Apr-14-25 | Reiterated | UBS | Buy |
| Apr-14-25 | Reiterated | Wells Fargo | Overweight |
| Mar-20-25 | Initiated | Scotiabank | Sector Outperform |
| Mar-13-25 | Upgrade | DA Davidson | Neutral → Buy |
| Jan-17-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-06-25 | Reiterated | Piper Sandler | Overweight |
| Oct-31-24 | Reiterated | BMO Capital Markets | Outperform |
| Oct-10-24 | Reiterated | Goldman | Buy |
| Oct-08-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-23-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jun-10-24 | Initiated | New Street | Buy |
| Jun-07-24 | Reiterated | Oppenheimer | Outperform |
| Apr-17-24 | Reiterated | Wells Fargo | Overweight |
| Apr-12-24 | Reiterated | BMO Capital Markets | Outperform |
| Apr-11-24 | Reiterated | Morgan Stanley | Overweight |
| Mar-21-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Jan-18-24 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Dec-13-23 | Initiated | Truist | Buy |
| Dec-05-23 | Initiated | China Renaissance | Buy |
| Oct-26-23 | Upgrade | HSBC Securities | Hold → Buy |
| Oct-17-23 | Initiated | Loop Capital | Buy |
| Sep-25-23 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-15-23 | Initiated | HSBC Securities | Hold |
| Jul-24-23 | Reiterated | Goldman | Buy |
| Jul-24-23 | Reiterated | Raymond James | Outperform |
| Jul-21-23 | Reiterated | Goldman | Buy |
| Jul-19-23 | Reiterated | Barclays | Overweight |
| Jul-19-23 | Reiterated | BofA Securities | Buy |
| Jul-19-23 | Reiterated | Mizuho | Buy |
| Jul-19-23 | Reiterated | TD Cowen | Outperform |
| Jul-19-23 | Reiterated | Wells Fargo | Overweight |
| Jul-17-23 | Reiterated | Mizuho | Buy |
| Jul-14-23 | Upgrade | UBS | Neutral → Buy |
| Jul-13-23 | Reiterated | Oppenheimer | Outperform |
| Apr-26-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Apr-26-23 | Reiterated | Goldman | Buy |
| Apr-26-23 | Reiterated | Guggenheim | Sell |
| Apr-26-23 | Reiterated | JP Morgan | Overweight |
| Apr-26-23 | Reiterated | Jefferies | Buy |
| Apr-26-23 | Upgrade | Macquarie | Neutral → Outperform |
| Apr-26-23 | Reiterated | Mizuho | Buy |
| Apr-26-23 | Reiterated | MoffettNathanson | Market Perform |
| Apr-26-23 | Reiterated | Morgan Stanley | Overweight |
| Apr-26-23 | Reiterated | Oppenheimer | Outperform |
| Apr-26-23 | Reiterated | Piper Sandler | Overweight |
| Apr-26-23 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-26-23 | Reiterated | Raymond James | Outperform |
| Apr-26-23 | Reiterated | Rosenblatt | Buy |
| Apr-26-23 | Reiterated | Stifel | Buy |
| Apr-26-23 | Reiterated | TD Cowen | Outperform |
| Apr-26-23 | Reiterated | UBS | Neutral |
| Apr-26-23 | Reiterated | Wedbush | Outperform |
| Apr-26-23 | Reiterated | Wells Fargo | Overweight |
| Apr-26-23 | Reiterated | Wolfe Research | Outperform |
| Apr-24-23 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Apr-21-23 | Reiterated | BMO Capital Markets | Market Perform |
| Apr-20-23 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-19-23 | Reiterated | BofA Securities | Buy |
| Apr-19-23 | Reiterated | Citigroup | Buy |
| Apr-19-23 | Reiterated | Deutsche Bank | Buy |
| Jan-25-23 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jan-17-23 | Downgrade | Guggenheim | Neutral → Sell |
| Jan-05-23 | Initiated | DA Davidson | Buy |
| Jan-04-23 | Downgrade | UBS | Buy → Neutral |
| Nov-02-22 | Initiated | Macquarie | Neutral |
| Oct-14-22 | Reiterated | Morgan Stanley | Overweight |
| Sep-30-22 | Resumed | Raymond James | Outperform |
| Sep-22-22 | Initiated | MoffettNathanson | Hold |
| Aug-12-22 | Initiated | Guggenheim | Neutral |
| Jul-27-22 | Reiterated | BMO Capital Markets | Outperform |
| Jul-27-22 | Reiterated | Citigroup | Buy |
| Jul-27-22 | Reiterated | Cowen | Outperform |
| Jul-27-22 | Reiterated | Deutsche Bank | Buy |
| Jul-27-22 | Reiterated | Stifel | Buy |
| Jul-27-22 | Reiterated | Wedbush | Outperform |
| Jul-26-22 | Initiated | Itau BBA | Outperform |
| Jul-19-22 | Reiterated | Citigroup | Buy |
| Jun-29-22 | Initiated | Redburn | Buy |
| Apr-27-22 | Reiterated | BMO Capital Markets | Outperform |
| Apr-27-22 | Reiterated | Deutsche Bank | Buy |
| Apr-27-22 | Reiterated | Evercore ISI | In-line |
| Apr-27-22 | Reiterated | Stifel | Buy |
| Apr-27-22 | Reiterated | Wedbush | Outperform |
| Apr-27-22 | Reiterated | Wolfe Research | Outperform |
| Jan-26-22 | Reiterated | BMO Capital Markets | Outperform |
| Jan-26-22 | Reiterated | Citigroup | Buy |
| Jan-26-22 | Reiterated | Morgan Stanley | Overweight |
| Jan-26-22 | Reiterated | Oppenheimer | Outperform |
| Jan-12-22 | Reiterated | BMO Capital Markets | Outperform |
| Dec-22-21 | Initiated | SMBC Nikko | Outperform |
| Nov-22-21 | Initiated | Wells Fargo | Overweight |
| Nov-16-21 | Resumed | Credit Suisse | Outperform |
| Nov-02-21 | Initiated | Deutsche Bank | Buy |
| Oct-27-21 | Reiterated | Barclays | Overweight |
| Oct-27-21 | Reiterated | BofA Securities | Buy |
| Oct-27-21 | Reiterated | Cowen | Outperform |
| Oct-27-21 | Reiterated | Credit Suisse | Outperform |
| Oct-27-21 | Reiterated | Goldman | Buy |
| Oct-27-21 | Reiterated | Mizuho | Buy |
| Oct-27-21 | Reiterated | Morgan Stanley | Overweight |
| Oct-27-21 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-27-21 | Reiterated | Stifel | Buy |
| Sep-17-21 | Resumed | Rosenblatt | Buy |
| Sep-14-21 | Reiterated | Morgan Stanley | Overweight |
| Aug-20-21 | Reiterated | Mizuho | Buy |
| Jul-28-21 | Reiterated | Barclays | Overweight |
| Jul-28-21 | Reiterated | Bernstein | Outperform |
| Jul-28-21 | Reiterated | BofA Securities | Buy |
| Jul-28-21 | Reiterated | Citigroup | Buy |
| Jul-28-21 | Reiterated | Cowen | Outperform |
| Jul-28-21 | Reiterated | Credit Suisse | Outperform |
| Jul-28-21 | Reiterated | Griffin Securities | Buy |
| Jul-28-21 | Reiterated | Mizuho | Buy |
| Jul-28-21 | Reiterated | Morgan Stanley | Overweight |
| Jul-28-21 | Reiterated | Piper Sandler | Overweight |
| Jul-28-21 | Resumed | RBC Capital Mkts | Outperform |
| Jul-28-21 | Reiterated | Rosenblatt | Buy |
| Jul-28-21 | Reiterated | Stifel | Buy |
| Jul-28-21 | Reiterated | Wolfe Research | Outperform |
| Jul-22-21 | Reiterated | BofA Securities | Buy |
| Jul-22-21 | Reiterated | Citigroup | Buy |
| Jul-22-21 | Reiterated | Cowen | Outperform |
| Jul-22-21 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jun-23-21 | Reiterated | Wedbush | Outperform |
| May-13-21 | Initiated | Rosenblatt | Buy |
| Apr-23-21 | Initiated | Wolfe Research | Outperform |
| Apr-12-21 | Reiterated | BMO Capital Markets | Outperform |
| Apr-05-21 | Resumed | Credit Suisse | Outperform |
| Mar-16-21 | Resumed | Credit Suisse | Outperform |
| Mar-03-21 | Resumed | Citigroup | Buy |
| Jan-26-21 | Resumed | Raymond James | Strong Buy |
| Jan-22-21 | Initiated | Goldman | Buy |
| Dec-21-20 | Upgrade | Citigroup | Neutral → Buy |
| Dec-16-20 | Resumed | BofA Securities | Buy |
| Nov-24-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Nov-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Oct-14-20 | Resumed | UBS | Buy |
| Jul-23-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-20-20 | Reiterated | Stifel | Buy |
| Jul-15-20 | Reiterated | BMO Capital Markets | Outperform |
| Jul-09-20 | Reiterated | Wedbush | Outperform |
| Jun-24-20 | Reiterated | Argus | Buy |
| Jun-02-20 | Reiterated | Wells Fargo | Overweight |
| May-27-20 | Initiated | Summit Insights | Buy |
| Apr-30-20 | Reiterated | Griffin Securities | Buy |
| Jan-30-20 | Reiterated | Oppenheimer | Outperform |
| Jan-30-20 | Reiterated | Piper Sandler | Overweight |
| Jan-30-20 | Reiterated | RBC Capital Mkts | Outperform |
| Jan-30-20 | Reiterated | Raymond James | Strong Buy |
| Jan-30-20 | Reiterated | Stifel | Buy |
| Jan-30-20 | Reiterated | Wedbush | Outperform |
| Jan-30-20 | Reiterated | Wells Fargo | Overweight |
View All
Microsoft Corporation Stock (MSFT) Latest News
Microsoft Corporation Stock: Navigating AI Investments and Analyst Adjustments Amid Market Volatilit - AD HOC NEWS
Analyst Price Targets: Nvidia, Nebius, Microsoft Stocks with Major Upside in 2026News and Statistics - IndexBox
No BS: Using corporate jargon is really giving you away - AFR
A Fake headline Just Added and Erased $1.7 Trillion From the Stock Market - The Motley Fool
Melinda French Gates Almost Quit Microsoft At 25. Now She Has A Simple Rule for Giving Feedback Without Losing Your Cool: 'Being Clear Is Kind'Microsoft (NASDAQ:MSFT) - Benzinga
Reduce Your Business’s Software Spend: This Microsoft Office License Is $33 For Life - Entrepreneur
Microsoft Stock Plunges, But Wall Street Sees 60% Upside - TipRanks
Why There's Simply No Need For Microsoft Office Anymore - bgr.com
Microsoft: The Questions That Price Seems To Have Answered (NASDAQ:MSFT) - Seeking Alpha
Jim Cramer drops unexpected take on Microsoft stock - MSN
Microsoft releases Windows 11 KB5081494, KB5083482 setup and recovery updates - Neowin
Jefferies notes key takeaways from RSA event after meeting with Microsoft, CrowdStrike execs - MSN
Xbox Series X: Microsoft's Flagship Console Driving Gaming Innovation and Revenue Growth in 2026 - AD HOC NEWS
Microsoft stops rollout of the latest Windows 11 feature update due to installation errors - Neowin
Microsoft (MSFT) closes above ___ on March 30? Trading Odds & Predictions - Polymarket
Microsoft takes over a Texas AI data center expansion after OpenAI backs away - Tech Xplore
Independence Wealth Advisors LLC Takes Position in Microsoft Corporation $MSFT - MarketBeat
M. Kulyk & Associates LLC Acquires 1,788 Shares of Microsoft Corporation $MSFT - MarketBeat
Microsoft Corporation $MSFT Shares Purchased by Gradient Investments LLC - MarketBeat
Microsoft Corporation $MSFT Shares Bought by NorthCrest Asset Manangement LLC - MarketBeat
Microsoft heads for worst quarter since 2008 amid AI concerns - Storyboard18
This Microsoft Office deal adds AI capabilities to your favorite apps - Mashable
Eli Lilly, UOB & Microsoft: This Week's Top Health Stories - Healthcare Digital
Microsoft Expands AI Infrastructure in Texas with Crusoe's 900MW Data Center - National Today
Asempa Wealth Advisors Takes Position in Microsoft Corporation $MSFT - MarketBeat
Microsoft halts hiring in cloud and North American sales groups: report - MSN
Vena: Acquisition Of Acterys To Expand AI-Driven Planning Across Microsoft Ecosystem - Pulse 2.0
The Microsoft 365 Built-In Security Feature: Microsoft Purview - AAG IT Services
Microsoft confirms major Windows 11 Search improvements after years of complaints - Windows Latest
Microsoft (NASDAQ:MSFT) Trading Down 2.5%What's Next? - MarketBeat
Microsoft Shares Slide as AI 'Bill' Comes Due: Can $140 Billion in Spending Justify the Returns? - FinancialContent
Microsoft Falls 25% as AI Spending Surge Raises Growth Questions - TradingView
Europe builds Microsoft-alternative ‘Euro-Office’ to reclaim digital sovereignty - Tech.eu
Microsoft is picking up a Texas data center project OpenAI didn't want, in a telling sign of how far they've drifted apart - Fortune
This new open-source office suite wants to replace Google Docs and Microsoft Office - How-To Geek
Grab a Microsoft Office 2021 Professional Plus digital license at 81% off - Neowin
Microsoft freezes hiring after laying off thousands amid rising AI costs - The American Bazaar
The latest Windows 11 update gives me hope Microsoft might actually fix things - MakeUseOf
Give your PC a spring refresh with this suite of Microsoft Office apps, just $5 each - Mashable
The train to Microsoft, Amazon and beyond opens this weekend - LinkedIn
Buy the Dip or Stay Away? Top Investor Weighs in on Microsoft Stock - tipranks.com
Microsoft Earns Top-Tier Ranking in Latest Forrester Customer Service Evaluation - Redmond Channel Partner
Seth Wilson: AI is my co-pilot; Microsoft Word tool is its own guide - The Indiana Lawyer
Lifetime Access To Microsoft Office Is Now Under $20 - PCMag
Daily Deal: The 2026 Microsoft Office Pro Courses Bundle - Techdirt.
Microsoft secures 900 MW AI capacity at Crusoe Texas campus with mid 2027 target - Crypto Briefing
Microsoft Stock (MSFT) Buckles under AI Worries, But Crowd Wisdom Has a Catch - TipRanks
Crusoe confirms Microsoft as customer at campus in Abilene, Texas - Data Center Dynamics
Microsoft (MSFT) Stock: Slips 1.69% as $900MW AI Campus Expands in Texas - CoinCentral
Microsoft stock sees 25% decline year-to-date - Latest news from Azerbaijan
Tech Moves: Smartsheet adds to C-suite; Armoire gets ML lead; past Microsoft director launches startup - GeekWire
Microsoft Corporation Stock (MSFT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):